Vanessa Vankerckhoven

Vanessa Vankerckhoven is CEO and co-founder of Idevax, medical device company active in drug delivery devices. Previously, she co-founded Novosanis in 2013 as a spin-off company of the University of Antwerp, successfully led the company through the acquisition by Orasure Technologies Inc, and was CEO until October 2022. She’s a passionate entrepreneur and guest professor at the Faculty of the Medicine and Health Sciences (University of Antwerp).

Prior to founding Novosanis she was Research and Innovation Manager of the Institute for Vaccines and Infectious Diseases (University of Antwerp). She began her career in 2000 at the Laboratory for Medical Microbiology (University of Antwerp).

Vanessa Vankerckhoven has a PhD in Medical Sciences (University of Antwerp) and has a special interest in infectious diseases, microbiology, vaccinology, medical devices, and diagnostics.